Lixin Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lixin Sun has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Hongjin Wang
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China
6 shared publicationsCaihong Li
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China
3 shared publicationsHao Zhang
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China
3 shared publicationsJiaxue Wang
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China
3 shared publicationsFeixu Qin
Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
2 shared publications- Guanghou Wang
R&D Center, Beijing Sciecure Pharmaceutical Co., Ltd., Beijing, PR China
2 shared publications
Latest Publications
- 2 April 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (5) , 100291
Evidence for endogenous amine conjugation and cytotoxicity arising from metabolic activation of trazodone
- 2 April 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (5) , 100291
Evidence for endogenous amine conjugation and cytotoxicity arising from metabolic activation of trazodone
- 25 September 2025
- Published by Elsevier in Journal of Chromatography B
- Vol. 1267, 124802
Metabolic and pharmacokinetic differences of Huai Hua san in Sprague Dawley and ulcerative colitis rats
- 25 September 2025
- Published by Elsevier in Journal of Chromatography B
- Vol. 1267, 124802
Metabolic and pharmacokinetic differences of Huai Hua san in Sprague Dawley and ulcerative colitis rats
- 4 March 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 260, 116793
Exploration of material basis: Chemical composition profile and metabolic profile in Xiao Jianzhong Granules
- 4 March 2025
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 260, 116793
Exploration of material basis: Chemical composition profile and metabolic profile in Xiao Jianzhong Granules
- 10 September 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1247, 124309
Identification of chemical constituents and pharmacokinetic characteristics of Xiaoyan Tuire Granule in rats
- 10 September 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1247, 124309
Identification of chemical constituents and pharmacokinetic characteristics of Xiaoyan Tuire Granule in rats
- 12 June 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1242, 124197
Integrated metabolomics and network pharmacology approach to exploring the anti-inflammatory mechanisms of Chuanwang xiaoyan capsules
- 12 June 2024
- Published by Elsevier in Journal of Chromatography B
- Vol. 1242, 124197
Integrated metabolomics and network pharmacology approach to exploring the anti-inflammatory mechanisms of Chuanwang xiaoyan capsules
- 22 May 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 247, 116241
Exploring the gut microbiota mediated biotransformation of Senecio scandens Buch.-Ham.: Insights from metabolite spectrum with UHPLC-Q-Orbitrap HRMS and bioinformatics analysis of gut microbiota metabolites
- 22 May 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 247, 116241
Exploring the gut microbiota mediated biotransformation of Senecio scandens Buch.-Ham.: Insights from metabolite spectrum with UHPLC-Q-Orbitrap HRMS and bioinformatics analysis of gut microbiota metabolites
- 9 May 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 246, 116207
Identification of Scutebarbatine B metabolites in rats using UHPLC-Q-Orbitrap-MS/MS and exploration of its mechanism of reversal multidrug resistance in breast cancer by network pharmacology and molecular docking studies
- 9 May 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 246, 116207
Identification of Scutebarbatine B metabolites in rats using UHPLC-Q-Orbitrap-MS/MS and exploration of its mechanism of reversal multidrug resistance in breast cancer by network pharmacology and molecular docking studies
- 1 August 2023
- Published by Wiley in Journal of Separation Science
- Vol. 46 (19) , e2200793
Characterization of chemical ingredients and in rats metabolic profiling of Lingyang Qingfei pills via ultra‐high‐performance liquid chromatography combined with Quadrupole‐Exactive Orbitrap high‐resolution mass spectrometry
Lingyang Qingfei pills (LQP), the renowned traditional Chinese medicine recipe, have been extensively utilized for the therapy of xerostomia, sore throat, bronchiolitis, and pneumonia in clinics. However, its phytochemicals remain equivocal, which severely limits the development of quality control and activity mechanisms. In the current research, a trusted method founded on ultra‐high performance liquid chromatography with Quadrupole‐Exactive Orbitrap mass spectrometry technique was proposed for the comprehensive screening of in vitro and in vivo chemical compositions of LQP. As a consequence, 239 constituents were preliminarily characterized, 37 of which were accurately confirmed by reference standards. In addition, a total of 208 xenobiotics, containing 71 absorbed prototypes and 137 metabolites, were revealed in rat plasma, bile, urine, and feces, respectively. The metabolic reaction of hydrolysis, hydroxylation, methylation, glycosylation, sulfation, and mixed‐mode was detected in the biotransformations of flavonoids, terpenoids, alkaloids, anthraquinones, organic acids, phenylpropanoids, and so forth. And 12 of the metabolites were new compounds. This experiment acted as the first reference for chemical substances and metabolites of LQP, which could provide valuable chemical information for further clarifying pharmacodynamic substances and pharmacokinetic studies.
- 1 August 2023
- Published by Wiley in Journal of Separation Science
- Vol. 46 (19) , e2200793
Characterization of chemical ingredients and in rats metabolic profiling of Lingyang Qingfei pills via ultra‐high‐performance liquid chromatography combined with Quadrupole‐Exactive Orbitrap high‐resolution mass spectrometry
Lingyang Qingfei pills (LQP), the renowned traditional Chinese medicine recipe, have been extensively utilized for the therapy of xerostomia, sore throat, bronchiolitis, and pneumonia in clinics. However, its phytochemicals remain equivocal, which severely limits the development of quality control and activity mechanisms. In the current research, a trusted method founded on ultra‐high performance liquid chromatography with Quadrupole‐Exactive Orbitrap mass spectrometry technique was proposed for the comprehensive screening of in vitro and in vivo chemical compositions of LQP. As a consequence, 239 constituents were preliminarily characterized, 37 of which were accurately confirmed by reference standards. In addition, a total of 208 xenobiotics, containing 71 absorbed prototypes and 137 metabolites, were revealed in rat plasma, bile, urine, and feces, respectively. The metabolic reaction of hydrolysis, hydroxylation, methylation, glycosylation, sulfation, and mixed‐mode was detected in the biotransformations of flavonoids, terpenoids, alkaloids, anthraquinones, organic acids, phenylpropanoids, and so forth. And 12 of the metabolites were new compounds. This experiment acted as the first reference for chemical substances and metabolites of LQP, which could provide valuable chemical information for further clarifying pharmacodynamic substances and pharmacokinetic studies.
- 20 March 2023
- Published by Taylor & Francis in Natural Product Research
- Vol. 38 (4) , 607-613
Two new indole alkaloids from Nauclea officinalis and their evaluation for cytotoxic activities
Two new indole alkaloids, naucleamide H (1) and (±)-19-O-butylangustoline (8), along with seven known alkaloids, 3,14-dihydroangustine (2), (-)-naucleofficine D (3a), (+)-naucleofficine D (3b), nauclefine (4), angustidine (5),19-O-ethylangustoline (6) and angustine (7) were isolated from the water extract of Nauclea officinalis. The structures of these compounds were established by spectroscopic analysis. Among them, the cytotoxicity of 1, 2, 6 and 8 were evaluated against six human cancer cell lines (HepG-2, SKOV3, HeLa, SGC 7901, MCF-7 and KB) in vitro for the first time with 5-fluorouracil as a positive control drug. The new compound 1 had a strong inhibitory effect on the proliferation of HepG-2 with an IC50 value of 19.59 μg/mL. The new compound 8 had a strong inhibitory effect on HepG-2, SKOV3, HeLa, MCF-7 and KB, IC50 value was 5.530, 23.11, 31.30, 32.42 and 37.26 μg/mL, respectively. GRAPHICAL ABSTRACT
- 20 March 2023
- Published by Taylor & Francis in Natural Product Research
- Vol. 38 (4) , 607-613
Two new indole alkaloids from Nauclea officinalis and their evaluation for cytotoxic activities
Two new indole alkaloids, naucleamide H (1) and (±)-19-O-butylangustoline (8), along with seven known alkaloids, 3,14-dihydroangustine (2), (-)-naucleofficine D (3a), (+)-naucleofficine D (3b), nauclefine (4), angustidine (5),19-O-ethylangustoline (6) and angustine (7) were isolated from the water extract of Nauclea officinalis. The structures of these compounds were established by spectroscopic analysis. Among them, the cytotoxicity of 1, 2, 6 and 8 were evaluated against six human cancer cell lines (HepG-2, SKOV3, HeLa, SGC 7901, MCF-7 and KB) in vitro for the first time with 5-fluorouracil as a positive control drug. The new compound 1 had a strong inhibitory effect on the proliferation of HepG-2 with an IC50 value of 19.59 μg/mL. The new compound 8 had a strong inhibitory effect on HepG-2, SKOV3, HeLa, MCF-7 and KB, IC50 value was 5.530, 23.11, 31.30, 32.42 and 37.26 μg/mL, respectively. GRAPHICAL ABSTRACT
- 28 June 2022
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 25 (4) , 369-378
Synthesis and antitumor activity of erysolin and its metabolites
Erysolin and its two metabolites which were found in blood, ERY-GSH and ERY-NAC, were synthesized by alkylation, amination, isothiocyanation and oxidation reactions from 1-bromo-4-chlorobutane and sodium methyl mercaptide. The reaction temperature, time, feed ratios and purification method were also optimized. The synthesis method was simple, green, safe and low-cost. Erysolin, ERY-GSH and ERY-NAC showed good antitumor activities against MCF-7, HeLa, HepG2, A549 and SW480 cells, which suggested that the antitumor mechanism of erysolin can also be clarified from its metabolites in addition to itself. Graphical Abstract
- 28 June 2022
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 25 (4) , 369-378
Synthesis and antitumor activity of erysolin and its metabolites
Erysolin and its two metabolites which were found in blood, ERY-GSH and ERY-NAC, were synthesized by alkylation, amination, isothiocyanation and oxidation reactions from 1-bromo-4-chlorobutane and sodium methyl mercaptide. The reaction temperature, time, feed ratios and purification method were also optimized. The synthesis method was simple, green, safe and low-cost. Erysolin, ERY-GSH and ERY-NAC showed good antitumor activities against MCF-7, HeLa, HepG2, A549 and SW480 cells, which suggested that the antitumor mechanism of erysolin can also be clarified from its metabolites in addition to itself. Graphical Abstract